Behind the work
+
Healthcare Projects Delivered
+
Biotech & MedTech Clients
x
Average Client ROI
+
Medicines Brought To Market
Three Areas of Focus
Recalcitrant Conditions
Lymphoma
We support teams working at the forefront of lymphoma research and treatment—developing innovative solutions that improve diagnostics, accelerate drug development, and bring new hope to patients. From targeted therapies to translational strategies, our work bridges science and impact in one of oncology’s most complex landscapes.
Rheumatoid arthritis
We collaborate with teams advancing new therapies for rheumatoid arthritis—an autoimmune condition that demands nuanced, long-term solutions. From early-stage research to clinical development and patient engagement, our work supports innovations that aim to improve quality of life and slow disease progression.
Multiple myeloma
We support the development of novel therapies for multiple myeloma, a complex and relapsing blood cancer. From early discovery to late-stage commercialization, we help teams navigate scientific nuance, regulatory demands, and patient needs—accelerating progress in a space where innovation can be life-changing.
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
ME/CFS is a debilitating, multi-system disease characterized by post-exertional malaise, autonomic dysfunction, and impaired energy metabolism. We support teams advancing diagnostic tools, biomarker discovery, and therapeutic pathways by creating digital platforms that communicate complex findings with clarity and clinical rigor—driving collaboration, awareness, and translational impact.
Sickle cell disease (SCD)
Sickle Cell Disease (SCD) is a hereditary blood disorder characterized by the production of abnormal hemoglobin, known as hemoglobin S. This mutation causes red blood cells to assume a rigid, sickle-like shape, leading to reduced oxygen delivery, chronic anemia, and painful vaso-occlusive episodes. Over time, these misshapen cells can obstruct blood vessels and cause organ damage. Common complications include stroke, acute chest syndrome, and increased susceptibility to infections.
Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease in which the immune system mistakenly attacks the body's own tissues. It can affect virtually any organ system, with common involvement of the skin, joints, kidneys, blood, and the nervous system. The course is often relapsing and remitting: periods of flare ups alternating with milder activity or partial remission.
Chronic Lymphocytic Leukemia (CLL)
CLL is a slow-growing cancer of the blood and bone marrow that affects lymphocytes, a type of white blood cell. It often develops in older adults and may initially be asymptomatic. Over time, it can lead to fatigue, swollen lymph nodes, and infections. Treatment depends on disease progression and may include targeted therapies, immunotherapy, or chemotherapy.
Osteoarthritis of the Knee
Osteoarthritis of the knee is a degenerative joint disease caused by the gradual breakdown of cartilage. It leads to pain, stiffness, swelling, and reduced mobility, often worsening over time. Common in older adults, it can significantly impact quality of life and is managed through a combination of physical therapy, medications, lifestyle changes, and, in some cases, joint replacement surgery.
Crohn’s Disease
Crohn’s disease is a chronic inflammatory bowel condition that can affect any part of the gastrointestinal tract, most commonly the small intestine and colon. It causes abdominal pain, diarrhea, weight loss, and fatigue, with periods of remission and flare-ups. While there is no cure, targeted therapies can control inflammation and improve long-term outcomes.